当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Predicting the future of patients with idiopathic pulmonary fibrosis: another step forward
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2017-11-14 , DOI: 10.1016/s2213-2600(17)30436-8
Fabrizio Luppi

Idiopathic pulmonary fibrosis (IPF), the most lethal form of interstitial pneumonia of unknown cause, is associated with a specific radiological or histopathological pattern (the so-called usual interstitial pneumonia pattern) and has a median survival estimated to be between 3 and 5 years after diagnosis.1 However, evidence shows that IPF has different clinical phenotypes, which are characterised by a variable disease course over time.2 At present, the natural history of IPF is unpredictable for individual patients, although some genetic factors and circulating biomarkers have been associated with different prognoses.

中文翻译:

预测特发性肺纤维化患者的未来:向前迈出的又一步

特发性肺纤维化(IPF)是原因不明的间质性肺炎最致命的形式,与特定的放射学或组织病理学模式(所谓的通常的间质性肺炎模式)相关,中位生存期估计为3至5年诊断后。1但是,有证据表明IPF具有不同的临床表型,其特征是随着时间的推移会改变病程。2目前,尽管某些遗传因素和循环生物标志物已与不同的预后相关,但个别患者的IPF的自然病程尚无法预测。
更新日期:2017-11-15
down
wechat
bug